Navigation Links
Polymer coatings based on molecular structures
Date:12/18/2013

This news release is available in German.

A novel method developed by researchers from Karlsruhe Institute of Technology (KIT) and Jacobs University Bremen enables manufacturing of polymer layers with tailor-made properties and multiple functions: A stable porous gel (SURGEL) for biological and medical applications is obtained from a metal-organic framework (SURMOF) grown up on a substrate. The method is presented in the renowned Journal of the American Chemical Society.

Coating of solids with polymers plays a central role in many areas of technological, natural and life sciences. For example, implants for the human body e.g., cardiac pacemakers, stents, or joint prostheses, need to be coated with suitable biomaterials and then impregnated with medical agents to accelerate healing-in and suppress inflammations. KIT researchers now have developed a completely novel method for producing a gel from cross-linked organic components. "Compared to conventional polymer coatings, this gel stands out by the fact that the pore size of the layers can be specifically adapted to the bioactive substances e.g., to pharmaceutical agents, to be embedded," explains Professor Christof Wll, Head of KIT's Institute of Functional Interfaces (IFG).

The gel fabrication method developed by researchers from the KIT Institute of Functional Interfaces (IFG), Institute for Biological Interfaces (ITG), and Institute for Organic Chemistry (IOC) together with the Jacobs University Bremen consists of several steps: First, a layer of a so-called metal-organic framework (MOF) is grown up on a solid substrate. In the obtained SURMOF (SURface-mounted Metal Organic Framework) layer, the size, shape, and chemical functionality of the pores can be tailored, so to speak. The layer itself, however, is not suited for use in biological environments: Its pronounced sensitivity to water causes it to be degraded very rapidly and the copper ions contained in that special type of SURMOF are toxic to living beings.

In view of the above, the molecular components in the SURMOF are cross-linked with another molecule in a second step using the particularly efficient so-called click chemistry method which already at room temperature allows a complete reaction. In a third step, one dissolves out the copper ions from the framework until obtaining the remaining cross-linked organic components that form a porous polymer. This SURGEL provides a uniformly thick layer and combines the advantages of the SURMOF with a high stability under biological conditions.

The potential for biological and medical applications was demonstrated by the researchers by impregnating the SURGEL with a bioactive molecule and then populating it with microbes. The behavior of these simple cells showed that the released messenger molecules were incorporated extremely efficiently. "This new material class opens up entirely new possibilities of influencing cellular growth," says Professor Martin Bastmeyer from KIT's Zoological Institute who together with Professor Wll heads the program "BioGrenzflchen" (biointerfaces) supported by the Helmholtz Association.

Both implementation of the novel polymer coating and its subsequent biological characterization have been demanding interdisciplinary cooperation of researchers in organic chemistry, biology, and physical chemistry from KIT and theorists from Jacobs University Bremen.


'/>"/>

Contact: Monika Landgraf
49-721-608-47414
Karlsruher Institut fr Technologie (KIT)
Source:Eurekalert  

Related medicine news :

1. Fluoropolymer Market is Growing at a CAGR of 5.7% & to Reach $9,797.4 Million by 2018 - New Report by MarketsandMarkets
2. Polymer Emulsion Market Expected to Reach 14,827.0 Kilotons by 2018 - New Report by MarketsandMarkets
3. Worldwide Medical Polymer Markets: 2013-2020
4. Fluoropolymer Market (PTFE, PVDF, FEP, Fluoroelastomers) worth $9,797.4 Million by 2018 - New Report by MarketsandMarkets
5. Advanced Functional Materials Market (Nanomaterials, Conductive Polymers) for Low Carbon Applications Worth 10,322.0 Kilotons by 2018 - New Report by MarketsandMarkets
6. Marshall Fong Joins FMC BioPolymer as Global Marketing Director of Food Ingredients
7. Ethanol Leads Renewable Chemicals Market; Polymers Sector 14.3% CAGR Growth Forecasted by 2018 Says New Research Report at ReportsnReports.com
8. Mainz University obtains new CRC Nanodimensional polymer therapeutics for tumor therapy
9. Polymer platform technology innovates drug delivery
10. New electrically-conductive polymer nanoparticles can generate heat to kill colorectal cancer cells
11. Singular polymer, multiple functions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Polymer coatings based on molecular structures
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: